Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Histogen Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 25 | 23 | −2 |
| Shares | 8.31M | 4.01M | −4.31M (−51.8%) |
| Value | $2.76M | $1.00M | −$1.76M (−63.8%) |
New holders (4)
Institutions that held Histogen Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 155,439 | $39.0K | 0.00% |
| JPMorgan Chase & Co | 3,443 | $1.00K | 0.00% |
| FMR LLC | 100 | $0 | 0.00% |
| Royal Bank of Canada | 300 | $0 | 0.00% |
Sold out (6)
Institutions that held Histogen Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Armistice Capital, LLC | 4,941,178 | $1.64M |
| Citadel Advisors LLC | 51,192 | $17.0K |
| Jane Street Group, LLC | 28,837 | $10.0K |
| Two Sigma Securities, LLC | 12,982 | $4.00K |
| Ellevest, Inc. | 15 | $0 |
| Tyler-Stone Wealth Management | 100 | $0 |